太阳能电池用锗晶片
Search documents
云南锗业:光伏级锗产品为太阳能电池用锗晶片
Zheng Quan Ri Bao Wang· 2025-12-29 13:13
证券日报网讯 12月29日,云南锗业(002428)在互动平台回答投资者提问时表示,公司的光伏级锗产 品为太阳能电池用锗晶片,主要运用于生产太阳能锗电池等;太阳能锗电池具有光电转换效率高、性能 稳定等特点,多用于空间飞行器(如卫星)等领域。 ...
云南锗业(002428.SZ):光伏级锗产品为太阳能电池用锗晶片,主要运用于生产太阳能锗电池等
Ge Long Hui· 2025-12-29 07:00
格隆汇12月29日丨云南锗业(002428.SZ)在互动平台表示,公司的光伏级锗产品为太阳能电池用锗晶 片,主要运用于生产太阳能锗电池等;太阳能锗电池具有光电转换效率高、性能稳定等特点,多用于空 间飞行器(如卫星)等领域。 ...
云南锗业:公司的光伏级锗产品为太阳能电池用锗晶片
Zheng Quan Ri Bao Wang· 2025-12-18 11:43
证券日报网讯12月18日,云南锗业(002428)在互动平台回答投资者提问时表示,公司的光伏级锗产品 为太阳能电池用锗晶片,主要运用于生产太阳能锗电池等;太阳能锗电池具有光电转换效率高、性能稳 定等特点,多用于空间飞行器(如卫星)等领域。 ...
云南锗业: 2025年半年度财务报告
Zheng Quan Zhi Xing· 2025-08-21 16:59
Core Viewpoint - The financial report of Yunnan Lincang Xinyuan Germanium Co., Ltd. for the first half of 2025 indicates significant changes in both assets and liabilities, with a notable increase in total assets and a decrease in net profit compared to the previous year [2][6]. Financial Performance - Total operating revenue for the first half of 2025 reached CNY 529.50 million, up from CNY 348.13 million in the same period of 2024, representing a growth of approximately 52% [4]. - Total operating costs increased to CNY 522.20 million from CNY 380.21 million, marking a rise of about 37% [4]. - The net profit for the first half of 2025 was CNY -11.52 million, a decline from a profit of CNY 0.33 million in the first half of 2024 [6]. Assets and Liabilities - Total assets at the end of the reporting period amounted to CNY 3.49 billion, compared to CNY 3.18 billion at the beginning of the year, reflecting an increase of approximately 10% [2][3]. - Current assets totaled CNY 1.92 billion, up from CNY 1.59 billion, indicating a growth of about 20% [2]. - Total liabilities increased to CNY 1.97 billion from CNY 1.67 billion, which is an increase of around 18% [3]. Cash Flow - The net cash flow from operating activities was CNY -131.90 million, worsening from CNY -83.10 million in the previous year [7]. - Cash and cash equivalents at the end of the period were CNY 373.25 million, down from CNY 49.87 million at the beginning of the year [7]. Shareholder Equity - Total equity attributable to shareholders was CNY 1.46 billion, slightly up from CNY 1.45 billion at the beginning of the year [3][8]. - The basic and diluted earnings per share for the first half of 2025 were CNY 0.034, compared to CNY -0.014 in the same period of 2024 [5].
龙虎榜 | 佛山系、城管希“火速撤离”山河智能,作手新一豪掷1亿扫货云南锗业
Ge Long Hui· 2025-07-30 00:47
Market Overview - On July 29, the total trading volume of the Shanghai and Shenzhen stock markets reached 1.8 trillion yuan, an increase of 609 billion yuan compared to the previous trading day [1] - Sectors that saw significant gains included CRO, innovative drugs, steel, CPO, and advanced packaging, while sectors that experienced declines included insurance, pork, banking, precious metals, and agriculture [1] Top Stocks on the Dragon and Tiger List - The top three net buying stocks on the Dragon and Tiger list were Yunnan Zhiye, Zhongsheng Pharmaceutical, and Ruizhi Pharmaceutical, with net purchases of 244 million yuan, 181 million yuan, and 165 million yuan respectively [2] - The top three net selling stocks were Tibet Tianlu, Xining Special Steel, and Boyun New Materials, with net sales of 482 million yuan, 183 million yuan, and 146 million yuan respectively [3] Institutional Activity - Among stocks with institutional special seats, the top three net buying stocks were Beifang Changlong, Ruizhi Pharmaceutical, and Zhongsheng Pharmaceutical, with net purchases of 117 million yuan, 89.74 million yuan, and 83.09 million yuan respectively [4] - The top three net selling stocks with institutional special seats were Shanghai Film, Boyun New Materials, and Aiying Room, with net sales of 62.16 million yuan, 59.90 million yuan, and 45.29 million yuan respectively [4] Notable Stock Performances - Yunnan Zhiye, a leader in the germanium industry, saw a trading halt with a turnover rate of 12.92% and a total transaction amount of 2.077 billion yuan. The company expects a net profit of 16 million to 23 million yuan for the mid-year report, representing a year-on-year increase of 273% to 348% [5] - Ruizhi Pharmaceutical, focused on CRO and ADC services, also experienced a trading halt with a turnover rate of 24.95% and a total transaction amount of 1.534 billion yuan. The company anticipates a net profit of 170 million to 210 million yuan for the mid-year report, reflecting a year-on-year growth of 94.49% to 140.25% [7] - Xining Special Steel and Tibet Tianlu both achieved trading halts, with turnover rates of 37.99% and 30.68% respectively, indicating strong market interest [13] Trading Dynamics - The trading dynamics showed significant activity from retail investors, with notable net purchases in stocks like Beiyang Changlong and Yunnan Zhiye, while there were substantial net sales in stocks like Boyun New Materials and Shanghai Film [16][19]